Quarry LP purchased a new stake in Aimei Health Technology Co., Ltd (NASDAQ:AFJK - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 150,000 shares of the company's stock, valued at approximately $1,605,000. Quarry LP owned 1.66% of Aimei Health Technology at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Virtu Financial LLC bought a new position in shares of Aimei Health Technology during the 3rd quarter worth about $123,000. Harraden Circle Investments LLC purchased a new position in Aimei Health Technology in the fourth quarter worth $1,117,000. Rivernorth Capital Management LLC increased its holdings in Aimei Health Technology by 9.1% during the third quarter. Rivernorth Capital Management LLC now owns 172,789 shares of the company's stock worth $1,811,000 after buying an additional 14,391 shares during the last quarter. Wolverine Asset Management LLC raised its holdings in shares of Aimei Health Technology by 21.3% in the 4th quarter. Wolverine Asset Management LLC now owns 654,039 shares of the company's stock worth $6,998,000 after purchasing an additional 115,000 shares during the period. Finally, Mizuho Securities USA LLC raised its stake in shares of Aimei Health Technology by 102.6% in the fourth quarter. Mizuho Securities USA LLC now owns 897,220 shares of the company's stock valued at $9,421,000 after buying an additional 454,442 shares during the period. Institutional investors own 45.58% of the company's stock.
Aimei Health Technology Stock Performance
NASDAQ:AFJK remained flat at $11.03 during mid-day trading on Friday. Aimei Health Technology Co., Ltd has a 12 month low of $10.24 and a 12 month high of $11.03. The firm has a 50 day moving average price of $10.98 and a 200-day moving average price of $10.78.
Aimei Health Technology (NASDAQ:AFJK - Get Free Report) last announced its quarterly earnings results on Friday, March 28th. The company reported $0.05 EPS for the quarter.
Aimei Health Technology Company Profile
(
Free Report)
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Further Reading
Before you consider Aimei Health Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimei Health Technology wasn't on the list.
While Aimei Health Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
